For more than fifty years, we have been trying to end the HIV epidemic, but many individuals from marginalized communities, including Black men who have sex with men (MSM), continue to face disproportionately high HIV rates. The introduction of pre-exposure prophylaxis (PrEP)- a prophylactic treatment- in 2012 has been a promising means of empowering vulnerable individuals to protect themselves. In fact, PrEP has been proven to significantly reduce the risk of HIV infection in high-risk populations when taken consistently.
The narrative of PrEP, particularly among Black MSM in the United States, depicts both progress and persistent challenges across medical, societal, and economic spheres. Black MSM in the US have been included in prior trials; however, their representation in the gold standard randomized, placebo-controlled trials remain inadequate, complicating efforts to fully understand PrEP’s efficacy in the context of this key population. “While we know it is broadly effective, we don’t currently have an estimate of the effect of PrEP specifically among Black MSM in the US, a subset of the population which has been disproportionately affected by the HIV epidemic since it began. Given that PrEP is likely effective in this population, performing a randomized placebo-controlled study would be unethical.” says Dr. Allison Meisner, an assistant professor at the Public Health Sciences Division at Fred Hutchinson Cancer Center.
Dr. Meisner and her colleagues, recently made strides in this area with their innovative research published in the MedRxiv, aiming to address the effects of PrEP on HIV risk among Black MSM in the US. Their study combined data from two non-randomized studies conducted by the HIV Prevention Trials Network (HPTN), both of which focused on Black MSM in the US but differing in design – one observational and the other a non-randomized open-label PrEP trial. Despite their rich insights, the lack of a randomized control group in both studies posed a challenge. To overcome this limitation, the team employed causal inference methods, a set of statistical techniques designed to estimate causal effects from observational data, to estimate the causal effect of PrEP on HIV risk in Black MSM in the US.
The authors focused on three critical stages of PrEP engagement: access, initiation without adherence, and adherence, using sophisticated methods like inverse probability weighting and marginal structural models. These approaches help unravel the complexity of factors at play, offering a robust estimate of how each stage affects HIV risk reduction. Their findings showed that access to PrEP, the initiation of its use, and consistent adherence all lowered the risk of HIV among Black MSM, though only initiation and adherence have statistically significant impacts on risk. The risk reduction ranged from 23% to 52%, depending on the level of engagement with PrEP. Dr. Meisner highlights the importance of this research, saying, “These results could encourage more Black MSM to initiate and adhere to PrEP, and may motivate health care professionals to take further steps to promote PrEP use among patients who are Black MSM.”
These findings confirm the revolutionary potential of PrEP in HIV prevention and highlights the critical role of accessibility and adherence in ensuring success. The methodology presented in this study provides a valuable model for future research, especially in scenarios where randomized controlled trials are not feasible, paving the way for broader inquiries into the effectiveness of PrEP and other health interventions. The implications of this research extend to policymaking, emphasizing the need for strategies that ensure accessibility and adoption of PrEP in communities at risk, including Black MSM. Additionally, the findings advocate for the development of supportive frameworks that not only distribute PrEP but also promote an environment conducive to its sustained use in public health initiatives. Such strategic insights are crucial for molding future research and policy, ensuring they are finely tuned to the nuances of the communities they aim to serve.
Future research could expand upon this foundation, examining different populations, settings, or long-term effects, enriching our grasp of PrEP's place in the broader narrative of HIV prevention. Delving into the psychosocial or systemic factors affecting PrEP adherence could offer a more holistic perspective, integral to crafting effective public health strategies and interventions. This pioneering study sheds new light on PrEP's efficacy in a key demographic, offering direction in the ongoing fight against HIV. Through innovative statistical approaches and a focus on real-world applicability, this research not only affirms PrEP's impact but also charts a course for future endeavors to enhance and refine HIV prevention strategies, particularly among Black MSM.
This study received support through grants from the National Institutes of Health (NIH).
Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium Member Dr. Allison Meisner contributed to this study.
Meisner, A., Xia, F., Chan, K. C. G., Mayer, K., Wheeler, D., Zangeneh, S., & Donnell, D. (2024). Estimating the Effect of PrEP in Black Men Who Have Sex with Men: A Framework to Utilize Data from Multiple Non-Randomized Studies to Estimate Causal Effects. medRxiv : the preprint server for health sciences, 2024.01.10.24301113.